1. Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly;Jorga;Clin Pharmacol Ther,1997
2. Effect of peripheral catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients;Nutt;Neurology,1994
3. Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations;Ruottinen;J Neurol Neurosurg Psychiatry,1996
4. Characteristics of catechol-O-methyltransferase (COMT) and properties of selective COMT inhibitors;Mannisto;Prog Drug Res,1992
5. RA Hauser ES Molho H Shale et al A pilot evalution of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Mov Disord (in press).